Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/17/26 17:03 | 3/16/26 | UPB | Health | Drug | Pharmaceutical Preparations | Gray Michael | MA | O | CFO,COO | S | -8 | 9.29 | 0 | -1 | -3 | 30 | D | ||||||||||||||
3/17/26 17:02 | 3/16/26 | UPB | Health | Drug | Pharmaceutical Preparations | Deykin Aaron | MA | O | Chief Me | S | -8 | 9.29 | 0 | -1 | -3 | 33 | D | ||||||||||||||
3/17/26 17:00 | 3/16/26 | UPB | Health | Drug | Pharmaceutical Preparations | Sutherland Everett Rand | MA | DO | CEO | S | -19 | 9.29 | 0 | -2 | -3 | 73 | D | ||||||||||||||
3/17/26 17:00 | 3/16/26 | UPB | Health | Drug | Pharmaceutical Preparations | Ambrose Allison | MA | O | GC | S | -4 | 9.29 | 0 | 0 | -3 | 17 | D | ||||||||||||||
3/17/26 16:59 | 3/16/26 | UPB | Health | Drug | Pharmaceutical Preparations | Houghton Adam | MA | O | Chief Bu | S | -6 | 9.29 | 0 | -1 | -3 | 24 | D | ||||||||||||||
10/17/24 16:19 | 10/15/24 | UPB | Health | Drug | Pharmaceutical Preparations | Chimovits Erez | MA | DT | P.d | 14,025 | 17.00 | 0 | 825 | 22 | 4,555 | I | |||||||||||||||
10/17/24 16:17 | 10/15/24 | UPB | Health | Drug | Pharmaceutical Preparations | Orbimed Advisors LLC | NY | DT | P.d | 14,025 | 17.00 | 0 | 825 | 22 | 4,555 | I | |||||||||||||||
10/17/24 16:05 | 10/15/24 | UPB | Health | Drug | Pharmaceutical Preparations | Ai Upstream LLC | NY | T | P.d | 19,975 | 17.00 | 0 | 1,175 | 27 | 5,494 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |